ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2011

Jan 4, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2011-01-03

Reporting Person: BURRIS MICHELLE (CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-03	Stock Option	$16.83	A	35000	Acquired	2021-01-03	Common (35000)	Direct

Footnotes

F1: The options vest in equal monthly installments over 48 months.